⬆
✘
 
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,
⌂ /ICD-10 diagnoses /
 Share

D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus

Add Analogs Compare
Found partially in the 18 (15) ⓘ✘Found partially in the 18 drugs (15 of these, according to Kiberis statistics) in 0 selected books (authors) ... hide
  Effect Influence Cases ⓘ ✘ Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • d82.3 immunodeficiency following hereditary defective response to epstein-barr virus
  •  83%+14%4   Hidden. Need a subscription
  • 63%+22%18 read Calcarea carbonica
    Immunodeficiency - E 63% (I 22%, 18 cases.); Heredity - E 0% (I -4%, 4 cases.)

    иммунодефицит,наследственность

    • ⇒ 93% +30% 8 with «adenoids»
    • ⇒ 91% +32% 3 with «desire for meat»
    • ⇒ 87% +41% 6 with «nasal congestion»
    • ⇒ 85% +21% 4 with «otitis»
    • ⇒ 80% +44% 7 with «ARVI»
    • ⇒ 76% +2% 4 with «outbursts of anger»
    • ⇒ 76% +2% 4 with «aggressive»
    • On average: 63% 22% 18 
    • ⇒ 46% +26% 7 with «chronic condition»
    • ⇒ 21% +5% 4 with «poor sleep»
  •  61%+11%15 read Phosphorus
    Immunodeficiency - E 61% (I 11%, 15 cases.); Heredity - E 10% (I 5%, 8 cases.)
  •  61%+36%5 read Baryta carbonica
  • 55%-6%17 read Mucosa compositum

    иммунодефицит,наследственность

    • ⇒ 72% +5% 9 with «inflammation»
    • ⇒ 68% +3% 8 with «ARVI»
    • ⇒ 61% +6% 9 with «runny nose»
    • On average: 55% -6% 17 
  •  54%+22%9 read Tuberculinum
    Immunodeficiency - E 54% (I 22%, 9 cases.); Heredity - E 14% (I -17%, 6 cases.)
  •  48%-10%6 read Sanicula aqua
  •  47%+19%14 read Pulsatilla nigricans
  •  46%+14%5 read Lymphomyosot
  •  43%+13%10 read Silica terra
    Immunodeficiency - E 43% (I 13%, 10 cases.); Heredity - E 12% (I 13%, 3 cases.)
  •  41%+15%8 read Natrum muriaticum
    Immunodeficiency - E 41% (I 15%, 8 cases.); Heredity - E 4% (I 9%, 7 cases.)
  • 31%+8%16 read Sulphur
    Immunodeficiency - E 31% (I 8%, 16 cases.); Heredity - E 0% (I -1%, 4 cases.)

    иммунодефицит,наследственность

    • ⇒ 63% +41% 4 with «hot patient»
    • ⇒ 47% +28% 8 with «runny nose»
    • On average: 31% 8% 16 
  • 15%-6%10 read Lycopodium clavatum

    иммунодефицит,наследственность

    • On average: 15% -6% 10 
    • ⇒ 0% -21% 4 with «inflammation»
  •  7%-10%7 read Arsenicum album
    Immunodeficiency - E 7% (I -10%, 7 cases.); Heredity - E 0% (I -1%, 3 cases.)
  •  0%+4%4 read Cina maritima
  •  Lachesis muta read
  •  Staphysagria read
  •  Thuja occidentalis read

Tree of ICD-10 diagnoses

  1. Description
  2. Related diseases
  3. Related clinical guidelines
  4. Basic medical services
  5. Clinics for treatment

Other names and synonyms

D82.3.

Description

There is no detailed description, see related

Related diseases

Related clinical guidelines

42a96bb5c8a2acfb07fc866444b97bf1
✘Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.